Thanks to their coronavirus vaccines, Pfizer, BioNTech and Moderna are making a combined profit of $ 65,000 per minute, according to a study by the People's Vaccine Alliance, which campaigns for a better distribution of vaccines around the world.
These pharmaceutical groups have amassed this money by selling the vast majority of their doses to rich countries, at the expense of less developed nations which remain very poorly vaccinated, deplores the association.
"Indecent"
According to its calculations, based on the results published by these companies, the trio will make pre-tax profits of $ 34 billion this year, or more than a thousand dollars per second, $ 65,000 per minute or $ 93.5 million per minute. day.
Pfizer, BioNTech and Moderna thus distinguish themselves from AstraZeneca and Johnson & Johnson, which currently sell their vaccines at cost price.
"It is indecent that a few companies are pocketing millions of dollars in profit every hour, when only 2% of people in low-income countries have been fully vaccinated against the coronavirus," lamented Maaza Seyoum of the African branch of People's Vaccine. Alliance and African Alliance.
Produce in poor countries
The alliance also laments that despite public funding of more than $ 8 billion, Pfizer, BioNTech and Moderna have all rejected calls to transfer vaccine technology to producers in low-income countries by the intermediary of the WHO, "a measure that could increase global supply, lower prices and save millions of lives."
The People's Vaccine Alliance, which counts among its 80 members Oxfam and Onusida, also urges the pharmaceutical giants to immediately lift the patents protecting anti-Covid vaccines, via an initiative of the World Trade Organization, around which negotiations continue.
Economy
Vaccination: Pfizer and Moderna have increased the price of their vaccine for the EU, reveals the "Financial Times"
Health
Vaccination: "The lifting of patents on vaccines must be decided collectively with the Europeans"
Video
Anti-covid vaccine
Covid 19
Pfizer-BioNTech
Coronavirus
Economy
Moderna
0 comment
0 share
Share on Messenger
Share on Facebook
Share on twitter
Share on Flipboard
Share on Pinterest
Share on Linkedin
Send by Mail
To safeguard
A fault ?
To print